| NCT00000320 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
|
PHASE1 |
View
|
| NCT00000318 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
|
PHASE2 |
View
|
| NCT00000312 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Alterations in Serotonergic Functions in Cocaine Addicts - 1
|
PHASE1 |
View
|
| NCT00000305 |
|
The University of Texas Health Science Center, Houston |
TERMINATED |
Amphetamine Cocaine Interaction Study - 2
|
PHASE1 |
View
|
| NCT00000304 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
|
PHASE2 |
View
|
| NCT00000303 |
|
University of California, Los Angeles |
COMPLETED |
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
|
PHASE2 |
View
|
| NCT00000302 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
|
PHASE3 |
View
|
| NCT00000295 |
Positive Gene Therapy |
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Progesterone Treatment in Female Smokers - 12
|
PHASE2 |
View
|
| NCT00000294 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Effects of Carvedilol on Cocaine Use in Humans - 11
|
PHASE2 |
View
|
| NCT00000293 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
|
PHASE3 |
View
|
| NCT00000292 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Acute Withdrawal From Smoked Cocaine - 9
|
PHASE1 |
View
|
| NCT00000269 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Pergolide Treatment for Substance Abusers - 4
|
PHASE2 |
View
|
| NCT00000268 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Cocaine Abuse and Attention Deficit Disorder - 3
|
NA |
View
|
| NCT00000267 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Risperidone Treatment in Dually-Diagnosed Individuals - 2
|
PHASE2 |
View
|
| NCT00000266 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
|
PHASE2 |
View
|
| NCT00000261 |
|
University of Chicago |
COMPLETED |
Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
|
PHASE2 |
View
|
| NCT00000260 |
|
University of Chicago |
COMPLETED |
Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
|
NA |
View
|
| NCT00000259 |
|
University of Chicago |
COMPLETED |
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
|
NA |
View
|
| NCT00000258 |
|
University of Chicago |
COMPLETED |
Role of Instructions in Nitrous Oxide Effects and Choice - 10
|
NA |
View
|
| NCT00000257 |
|
University of Chicago |
COMPLETED |
Effects of Alcohol History on Effects of Nitrous Oxide - 9
|
NA |
View
|
| NCT00000256 |
|
University of Chicago |
COMPLETED |
Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8
|
NA |
View
|
| NCT00000251 |
|
University of Chicago |
COMPLETED |
Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3
|
PHASE2 |
View
|
| NCT00000250 |
|
University of Chicago |
COMPLETED |
Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
|
PHASE2 |
View
|
| NCT00000235 |
Positive Gene Therapy |
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Alternate Day Buprenorphine Administration, Phase XII - 17
|
PHASE2 |
View
|
| NCT00000234 |
Positive Gene Therapy |
University of Vermont |
COMPLETED |
Alternate Day Buprenorphine Administration, Phase XI - 16
|
PHASE2 |
View
|
| NCT00000233 |
Positive Gene Therapy |
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Alternate Day Buprenorphine Administration, Phase X - 15
|
PHASE2 |
View
|
| NCT00000232 |
|
University of Vermont |
COMPLETED |
Alternate Day Buprenorphine Administration, Phase IX - 14
|
PHASE2 |
View
|
| NCT00000220 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Gradual Vs. Rapid Buprenorphine Detoxification - 2
|
PHASE1 |
View
|
| NCT00000218 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Pharmacotherapy and Intensive Treatment - 2
|
PHASE4 |
View
|
| NCT00000216 |
|
Yale University |
COMPLETED |
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
|
PHASE3 |
View
|
| NCT00000206 |
Positive Gene Therapy |
University of California, Los Angeles |
COMPLETED |
Clinical Rescue Protocol - 2
|
PHASE2 |
View
|
| NCT00000205 |
|
University of California, Los Angeles |
COMPLETED |
Buprenorphine Maintenance Protocol - 1
|
PHASE3 |
View
|
| NCT00000204 |
|
Yale University |
COMPLETED |
Buprenorphine Maintenance for Opioid Addicts - 3
|
PHASE2 |
View
|
| NCT00000203 |
|
Yale University |
COMPLETED |
Buprenorphine Maintenance for Opioid Addicts - 2
|
PHASE2 |
View
|
| NCT00000202 |
|
Yale University |
COMPLETED |
Buprenorphine Maintenance for Opioid Addicts - 1
|
PHASE2 |
View
|
| NCT00000200 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Cocaine Effects in Humans: Physiology and Behavior - 1
|
PHASE2 |
View
|
| NCT00000195 |
|
Yale University |
WITHDRAWN |
Neurobiology of Opioid Dependence: 4 - 4
|
PHASE2 |
View
|
| NCT00000194 |
|
Yale University |
WITHDRAWN |
Neurobiology of Opioid Dependence: 3 - 3
|
PHASE2 |
View
|
| NCT00000193 |
|
Yale University |
WITHDRAWN |
Neurobiology of Opioid Dependence: 2 - 2
|
PHASE2 |
View
|
| NCT00000192 |
|
Yale University |
WITHDRAWN |
Neurobiology of Opioid Dependence: 1 - 1
|
PHASE2 |
View
|
| NCT00000169 |
|
National Eye Institute (NEI) |
UNKNOWN |
The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
|
|
View
|
| NCT00000168 |
|
Johns Hopkins Bloomberg School of Public Health |
COMPLETED |
Longitudinal Study of Ocular Complications of AIDS (LSOCA)
|
|
View
|
| NCT00000167 |
|
National Eye Institute (NEI) |
COMPLETED |
Complications of Age-Related Macular Degeneration Prevention Trial
|
PHASE3 |
View
|
| NCT00000161 |
|
National Eye Institute (NEI) |
UNKNOWN |
Randomized Trials of Vitamin Supplements and Eye Disease
|
PHASE3 |
View
|
| NCT00000160 |
Positive Gene Therapy |
National Eye Institute (NEI) |
COMPLETED |
Diabetic Retinopathy Study (DRS)
|
PHASE3 |
View
|
| NCT00000159 |
|
National Eye Institute (NEI) |
COMPLETED |
Sorbinil Retinopathy Trial (SRT)
|
PHASE3 |
View
|
| NCT00000158 |
|
National Eye Institute (NEI) |
UNKNOWN |
Macular Photocoagulation Study (MPS)
|
PHASE3 |
View
|
| NCT00000157 |
|
National Eye Institute (NEI) |
TERMINATED |
Randomized Trial of Aspirin and Cataracts in U.S. Physicians
|
PHASE3 |
View
|
| NCT00000156 |
|
National Eye Institute (NEI) |
COMPLETED |
The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
|
PHASE3 |
View
|
| NCT00000151 |
|
National Eye Institute (NEI) |
COMPLETED |
Early Treatment Diabetic Retinopathy Study (ETDRS)
|
PHASE3 |
View
|
| NCT00000150 |
|
National Eye Institute (NEI) |
COMPLETED |
Submacular Surgery Trials (SST)
|
PHASE3 |
View
|
| NCT00000135 |
Positive Gene Therapy |
Johns Hopkins Bloomberg School of Public Health |
COMPLETED |
Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)
|
PHASE2 |
View
|
| NCT00000134 |
Positive Gene Therapy |
Johns Hopkins Bloomberg School of Public Health |
COMPLETED |
Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)
|
PHASE3 |
View
|
| NCT00000133 |
|
National Eye Institute (NEI) |
COMPLETED |
Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity
|
NA |
View
|
| NCT00000132 |
|
National Eye Institute (NEI) |
UNKNOWN |
Early Manifest Glaucoma Trial (EMGT)
|
PHASE3 |
View
|
| NCT00000120 |
|
National Eye Institute (NEI) |
COMPLETED |
Clinical Trial of Eye Prophylaxis in the Newborn
|
PHASE3 |
View
|
| NCT00000118 |
|
National Eye Institute (NEI) |
COMPLETED |
Ganciclovir Implant Study for Cytomegalovirus Retinitis
|
PHASE3 |
View
|
| NCT00000112 |
|
National Center for Research Resources (NCRR) |
UNKNOWN |
Prevalence of Carbohydrate Intolerance in Lean and Obese Children
|
|
View
|
| NCT00000105 |
Positive Gene Therapy |
Masonic Cancer Center, University of Minnesota |
TERMINATED |
Vaccination With Tetanus and KLH to Assess Immune Responses.
|
|
View
|
| NCT00000104 |
|
National Center for Research Resources (NCRR) |
COMPLETED |
Does Lead Burden Alter Neuropsychological Development?
|
|
View
|
| NCT00000102 |
Positive Gene Therapy |
National Center for Research Resources (NCRR) |
COMPLETED |
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
|
PHASE1 |
View
|